Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Hecht, Stephen S	University Of Minnesota United States	High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck	5R01CA263084-05	Wendy Wang, Ph.D., M.Sc.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-08	Guillermo Marquez, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-04	Wendy Wang, Ph.D., M.Sc.
Herrmann, Joerg	Mayo Clinic Rochester United States	TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial	5R01CA233610-06	Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.	University Of Minnesota United States	Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota	5R01CA276775-03	Amit Kumar, Ph.D.
Hill, Joshua Aiden	Fred Hutchinson Cancer Center United States	Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy	5R01CA276040-03	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hitchins, Megan P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	7R01CA252042-05	Matthew Young, Ph.D.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-09	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	4U01CA288375-03	Sidney Fu, M.D.
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06	Guillermo Marquez, Ph.D.
Howitt, Brooke E	Stanford University United States	Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping	1R37CA303960-01	Goli Samimi, Ph.D., M.P.H.
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-05	Claire Zhu, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	5R01CA272254-03	Rachel Altshuler, Ph.D.
Hu, Jim	Weill Medical Coll Of Cornell Univ United States	Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)	5R01CA259173-04	Marjorie Perloff, M.D.